Burns C. Blaxall, PhD, FACC, FAHA, Joins PGxAI as President & Chief Business Officer

PGxAI is proud to announce that Burns C. Blaxall, PhD, FACC, FAHA, FISHR, FAPS has joined the company as President and Chief Business Officer.

A recognized leader in precision medicine, implementation science, and translational research, Dr. Blaxall brings over two decades of experience transforming academic discoveries into clinical and commercial impact. Most recently, he served as Senior Vice President of Precision Medicine at Aranscia, where he led strategy and implementation across value-based care programs and health system partnerships. Prior to that, he founded and led the Precision Health program at The Christ Hospital Health Network, integrating genomics, clinical decision support, and AI tools into real-world patient care.

Dr. Blaxall is also widely recognized for establishing and scaling major research centers, including the Center for Translational Fibrosis Research and Heart Institute Clinical Research Core at Cincinnati Children’s. He has secured over $35 million in funding as PI or co-PI and delivered more than 200 invited lectures across six continents.

“Burns has spent his entire career advancing the shift from reactive to proactive care,” said Dr. Mike Zack, CEO and co-founder of PGxAI. “His unique combination of scientific leadership, business acumen, and deep clinical integration expertise is exactly what PGxAI needs as we scale real-time AI solutions like Betelgeuse and Deneb across healthcare and biopharma.”

Please join us in welcoming Dr. Blaxall to the PGxAI leadership team.

Contact us to explore collaboration opportunities.